Supplementary Table 2 from Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

Authors :: Elizabeth A. Mittendorf
George E. Peoples
Jarrod P. Holmes
Jason J. Lukas
Anne V. Philips
Na Qiao
Rashmi K. Murthy
Gheath Alatrash
Jennifer K. Litton
Annelies T. Hickerson
Timothy J. Vreeland
Diane Hale
G. Travis Clifton
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Clinicopathologic characteristics of randomized triple-negative breast cancer patients

Tools